Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Neuphoria Therapeutics Inc. | 74,088 | reported | 27 Aug 2025 | tx 3+331,559 |
| Lipocine Inc. | 7,174 | reported | 04 Jun 2025 | tx 6+87,267 |
| Vigil Neuroscience, Inc. | 4,000 | reported | 18 Nov 2022 | tx 4+4,300−600 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Aug 2025 | GRANT_AWARD | Neuphoria Therapeutics Inc. | 34,559 | 8.27 USD | deriv |
| 04 Jun 2025 | GRANT_AWARD | Lipocine Inc. | 1,764 | 3.20 USD | deriv |
| 16 Apr 2025 | GRANT_AWARD | Neuphoria Therapeutics Inc. | 270,000 | 5.16 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Lipocine Inc. | 1,764 | 7.05 USD | deriv |
| 10 May 2023 | GRANT_AWARD | Lipocine Inc. | 30,000 | 0.27 USD | deriv |
| 22 Nov 2022 | PURCHASE | Lipocine Inc. | 21,739 | 0.47 USD | |
| 18 Nov 2022 | SALE | Vigil Neuroscience, Inc. | 300 | 14.00 USD | |
| 18 Nov 2022 | EXERCISE | Vigil Neuroscience, Inc. | 300 | 1.89 USD | |
| 18 Nov 2022 | EXERCISE | Vigil Neuroscience, Inc. | 300 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | Lipocine Inc. | 22,000 | 0.92 USD | deriv |
| 03 May 2022 | PURCHASE | Vigil Neuroscience, Inc. | 4,000 | 3.40 USD | |
| 11 Apr 2022 | GRANT_AWARD | Lipocine Inc. | 10,000 | 1.16 USD | deriv |